Poster Abstract Session:
72. TB: Multidrug Resistant TB
Thursday, October 8, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: HIV-STD-TB, Global ID, Adult ID

Presentations:
568
A Pilot Study on Epidemiology of Drug Resistant Tuberculosis Among in Sub-Himalayan Valley of Himachal Pradesh, India – A Large Unmet Gap
Shubhanker Mitra, MD - Medicine ; Pradeep Zechariah, MBBS ; Philip Alexander, MS - Surgery ; Anna Alexander, MD - Medicine
570
Diabetes reduces the rate of sputum culture conversion in patients with primary multidrug resistant tuberculosis
Argita Salindri, MPH ; Maia Kipiani, MD ; Russell R Kempker, MD ; Neel Gandhi, MD ; Lasha Darchia, MD ; Nestani Tukvadze, MD ; Henry Blumberg, MD, FIDSA, FSHEA ; Matthew Magee, Ph.D.
571
Clinical impact of rpoB mutations conferring discordant phenotypic-genotypic rifampin resistance in Mycobacterium tuberculosis
Neha Shah, MD MPH ; Grace Lin, MS ; Pennan Barry, MD, MPH ; Gisela Schecter, MD, MPH ; Ed Desmond, PhD
572
Clinical Relevance of Routine Pyrazinamide Drug Susceptibility Testing in Multidrug-Resistant Tuberculosis
Gustavo E. Velásquez, M.D., M.P.H. ; Roger I. Calderon, Laboratory Director ; Carole D. Mitnick, Sc.D. ; Mercedes C. Becerra, Sc.D. ; Zibiao Zhang, Programmer/Analyst ; Carmen C. Contreras, Sub-Director of Research Projects ; Rosa M. Yataco, Data Coordinator ; Jerome T. Galea, Ph.D., M.S.W. ; Leonid W. Lecca, M.D. ; Megan B. Murray, MD, MPH, ScD

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.